NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of PACS Group, Inc. (“PACS”) common stock (NYSE: PACS). PACS operates skilled nursing and assisted living facilities. PACS had its IPO April 10, 2024 and sold 24.6 million shares at $21.00 per share. On September 5, 2024, PACS and its two co-founders sold 19.0 million shares at $36.25 per share in a secondary equity offering. During the trading day on November 4, 2024, Hindenburg Research is ...

文章核心观点 - PACS Group公司涉嫌通过滥用2020年至2023年期间的COVID-19豁免权,不当膨胀了Medicare收入 [2] - 这可能会给公司带来重大的监管风险 [2] 公司概况 - PACS Group是一家上市公司,股票代码为NYSE: PACS [1] - 公司股价在一天内下跌超过30% [2] 调查情况 - 律师事务所Block & Leviton正在调查PACS Group是否存在证券法违规行为 [1][4] - 投资者如果在PACS Group的投资中亏损,可以联系该律师事务所了解如何挽回损失 [1][3][5] - 如果有内部消息人士,可以考虑协助调查或通过SEC举报,有机会获得最高30%的奖励 [6] - Block & Leviton是一家著名的证券集体诉讼律所,曾为投资者挽回巨额损失 [7]

PACS Group, Inc. Reports Second Quarter 2024 Results August 12, 2024 Conference Call and Webcast scheduled for today, August 12, 2024, at 5:00 pm ET. FARMINGTON, Utah—(BUSINESS WIRE)—PACS Group, Inc. (NYSE: PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the second quarter of 2024. Highlights: • GAAP net income (loss) was $38.2 million for the six months ended June 30, 2024 and $ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to ______. Commission file number 001-42011 _________________________ PACS Group, Inc. (Exact name of ...

PACS Group, Inc. Reports First Quarter 2024 Results 05/13/2024 Conference Call and Webcast scheduled for tomorrow, May 14, 2024, at 4:00 pm ET. FARMINGTON, Utah—(BUSINESS WIRE)—PACS Group, Inc. (NYSE: PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the first quarter of 2024, reporting net income of $49.1 million, Adjusted EBITDA of $88.5 million and Adjusted EBITDAR of $152.5 mil ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to ______. Commission file number 001-42011 _________________________ PACS Group, ...